Amiodarone and thyroid physiology, pathophysiology, diagnosis and management
- PMID: 30309693
- PMCID: PMC6661016
- DOI: 10.1016/j.tcm.2018.09.005
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management
Abstract
Although amiodarone is considered the most effective antiarrhythmic agent, its use is limited by a wide variety of potential toxicities. The purpose of this review is to provide a comprehensive "bench to bedside" overview of the ways amiodarone influences thyroid function. We performed a systematic search of MEDLINE to identify peer-reviewed clinical trials, randomized controlled trials, meta-analyses, and other clinically relevant studies. The search was limited to English-language reports published between 1950 and 2017. Amiodarone was searched using the terms adverse effects, hypothyroidism, myxedema, hyperthyroidism, thyroid storm, atrial fibrillation, ventricular arrhythmia, and electrical storm. Google and Google scholar as well as bibliographies of identified articles were reviewed for additional references. We included 163 germane references in this review. Because amiodarone is one of the most frequently prescribed antiarrhythmic drugs in the United States, the mechanistic, diagnostic and therapeutic information provided is relevant for practicing clinicians in a wide range of medical specialties.
Keywords: Adverse effects; Amiodarone; Atrial fibrillation; Electrical storm; Hyperthyroidism; Hypothyroidism; Myxedema; Thyroid storm; Ventricular arrhythmia.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no relevant conflicts of interest.
Figures
Comment in
-
Editorial commentary: Amiodarone-induced thyroid diseases: Additional unintended consequences.Trends Cardiovasc Med. 2019 Jul;29(5):296-297. doi: 10.1016/j.tcm.2018.10.003. Epub 2018 Oct 13. Trends Cardiovasc Med. 2019. PMID: 31130186 No abstract available.
References
-
- Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007;298(11):1312–22. - PubMed
-
- Singh BN. Amiodarone as paradigm for developing new drugs for atrial fibrillation. J Cardiovasc Pharmacol 2008;52(4):300–5. - PubMed
-
- Rosenbaum MB,. Chiale PA, Haedo A, Lazzari JO, Elizari MV. Ten years of experience with amiodarone. Am Heart J 1983;106(4 Pt 2):957–64. - PubMed
-
- Rosenbaum MB, Chiale PA, Halpern MS. Nau GJ, Przybylski J, Levi RJ. et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 1976;38(7):934–44. - PubMed
-
- Fogoros RN. The Strange History of Amiodarone. Available at https://www.verywellhealth.com/the-strange-history-of-amiodarone-1745987... accessed 8/9/18.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
